Booz Allen Flat on Corsha Stake
Booz Allen Hamilton (NYSE: BAH) today announced that its corporate venture capital arm, Booz Allen Ventures, has made a strategic investment in Corsha, the first and only Machine Identity Provider built to secure communication across operational systems and critical infrastructure. This investment will accelerate the use of advanced technology solutions to reinforce U.S. defenses against increasingly sophisticated and frequent cyberattacks.Operating in demanding environments and working with key partners such as the U.S. Air Force, Corsha uses multi-factor authentication to secure machine-to-machine communication and proactively defend against emerging cyber threats. Corsha leverages advanced behavioral analytics to detect unusual patterns and spot potential threats, blocking adversaries’ access to American operational technology (OT), including within domestic defense manufacturing and other U.S. critical infrastructure.“The physical world is increasingly hyperconnected and software defined, leaving military installations, civilian critical infrastructure, and other hubs of economic and national security at risk of cyber disruption,” said David Forbes, director of cyber-physical defense at Booz Allen, based in McLean, Virginia. “Addressing identity verification challenges is a critical step towards creating more resilient systems. We invested in Corsha because we believe their technology can solve the identity problem and because we expect securing the physical world to be a significant growth vector in the cyber market.”BAH shares demurred eight cents to $107.22.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


